<DOC>
	<DOCNO>NCT00054392</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy gemcitabine , carboplatin , paclitaxel use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know chemotherapy regimen effective treat non-small cell lung cancer . PURPOSE : Randomized phase III trial compare effectiveness different combination chemotherapy regimens treat patient stage IIIB , stage IV , recurrent non-small cell lung cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Stage IIIB , Stage IV , Recurrent Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall survival patient stage IIIB IV recurrent non-small cell lung cancer treat gemcitabine carboplatin v gemcitabine paclitaxel v paclitaxel carboplatin . - Compare overall response rate time progression patient treat regimen . - Compare toxic effect regimens patient . - Compare quality life patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord weight loss within past 6 month ( less 5 % v least 5 % ) , disease stage ( IIIB v IV ) , brain metastasis ( present v absent ) . Patients randomize 1 3 treatment arm . - Arm I : Patients receive gemcitabine IV 30 minute day 1 8 carboplatin IV 15-30 minute day 1 . - Arm II : Patients receive gemcitabine IV 30 minute day 1 8 paclitaxel IV 3 hour day 1 . - Arm III : Patients receive paclitaxel IV 3 hour carboplatin IV 15-30 minute day 1 . In arm , treatment repeat every 3 week 6 course absence disease progression unacceptable toxicity . Quality life assess baseline , every 6 week study treatment , every 3 month progressive disease document . Patients follow every 3 month . PROJECTED ACCRUAL : A total 1,134 patient ( 378 per treatment arm ) accrue study within 2 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm nonsmall cell lung cancer ( NSCLC ) 1 follow type : Squamous cell Adenocarcinoma Large cell anaplastic Bronchoalveolar Nonsmall cell carcinoma otherwise specified NOTE : Mixed tumor categorize predominant cell type ( tumor smallcell anaplastic element ineligible ) Evidence least 1 follow : Clinically document recurrent disease prior radiation surgery Stage IV disease ( distant metastasis ) Stage IIIB disease present 1 follow : Pleural pericardial effusion CT scan chest xray Pleural implant document pathologically see CT scan xray Measurable evaluable disease No brain metastasis unless clinically stable surgery and/or radiotherapy PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 01 Life expectancy Not specify Hematopoietic Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic Bilirubin great 1.5 mg/dL AST le 5 time upper limit normal Renal Creatinine great 1.5 mg/dL OR Creatinine clearance least 40 mL/min Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No hypersensitivity agent contain Cremophor EL ( polyoxyethylated castor oil ) PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy advanced NSCLC Endocrine therapy Not specify Radiotherapy See Disease Characteristics Recovered prior radiotherapy No prior radiotherapy site measurable disease , unless site subsequent progression disease document physical exam , radiography , pathology No concurrent radiotherapy ( except brain metastasis ) Surgery See Disease Characteristics Other No concurrent aminoglycoside antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>adenosquamous cell lung cancer</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
</DOC>